| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Predisposition to Disease | 251 | 2023 | 17446 | 5.440 |
Why?
|
| Genome-Wide Association Study | 186 | 2024 | 12261 | 4.690 |
Why?
|
| Genetic Variation | 111 | 2023 | 6544 | 4.650 |
Why?
|
| Polymorphism, Single Nucleotide | 231 | 2023 | 15519 | 4.150 |
Why?
|
| Genome, Human | 93 | 2023 | 4420 | 3.400 |
Why?
|
| Genetics, Population | 30 | 2023 | 934 | 3.260 |
Why?
|
| Crohn Disease | 59 | 2023 | 2303 | 3.230 |
Why?
|
| Haplotypes | 78 | 2023 | 2779 | 3.070 |
Why?
|
| Mutation, Missense | 37 | 2023 | 2564 | 2.320 |
Why?
|
| Multifactorial Inheritance | 29 | 2023 | 1194 | 2.160 |
Why?
|
| Chromosome Mapping | 85 | 2019 | 4740 | 1.950 |
Why?
|
| Inflammatory Bowel Diseases | 33 | 2023 | 2425 | 1.880 |
Why?
|
| Linkage Disequilibrium | 57 | 2021 | 1997 | 1.810 |
Why?
|
| Models, Genetic | 43 | 2023 | 3494 | 1.710 |
Why?
|
| Child Development Disorders, Pervasive | 13 | 2015 | 615 | 1.680 |
Why?
|
| Macular Degeneration | 22 | 2023 | 980 | 1.650 |
Why?
|
| Schizophrenia | 40 | 2023 | 6882 | 1.570 |
Why?
|
| Disease | 13 | 2023 | 680 | 1.470 |
Why?
|
| Genotype | 109 | 2024 | 12951 | 1.430 |
Why?
|
| Colitis, Ulcerative | 35 | 2023 | 1912 | 1.390 |
Why?
|
| Genetic Linkage | 52 | 2016 | 2421 | 1.390 |
Why?
|
| Gene Frequency | 60 | 2023 | 3588 | 1.380 |
Why?
|
| Genetic Association Studies | 33 | 2024 | 2703 | 1.370 |
Why?
|
| Sequence Analysis, DNA | 42 | 2023 | 4803 | 1.360 |
Why?
|
| Genetic Loci | 28 | 2023 | 2575 | 1.300 |
Why?
|
| Phenotype | 96 | 2023 | 16365 | 1.300 |
Why?
|
| Mutation | 67 | 2023 | 29786 | 1.300 |
Why?
|
| Jews | 15 | 2023 | 385 | 1.290 |
Why?
|
| Genetic Markers | 42 | 2020 | 2634 | 1.270 |
Why?
|
| DNA Copy Number Variations | 20 | 2023 | 1941 | 1.270 |
Why?
|
| Genetics, Medical | 9 | 2020 | 338 | 1.240 |
Why?
|
| Finland | 36 | 2023 | 602 | 1.220 |
Why?
|
| Quantitative Trait Loci | 30 | 2023 | 2019 | 1.210 |
Why?
|
| Case-Control Studies | 110 | 2023 | 21746 | 1.200 |
Why?
|
| Genome | 24 | 2022 | 1808 | 1.190 |
Why?
|
| Alleles | 70 | 2023 | 6933 | 1.120 |
Why?
|
| Complement Factor H | 8 | 2023 | 110 | 1.090 |
Why?
|
| Mice, Inbred Strains | 11 | 2010 | 1827 | 1.050 |
Why?
|
| Awards and Prizes | 3 | 2019 | 375 | 1.020 |
Why?
|
| Software | 34 | 2023 | 4443 | 1.020 |
Why?
|
| Humans | 605 | 2024 | 744343 | 1.000 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 18 | 2023 | 3658 | 0.940 |
Why?
|
| Genomics | 25 | 2023 | 5720 | 0.920 |
Why?
|
| Autistic Disorder | 11 | 2023 | 1185 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 44 | 2024 | 11725 | 0.870 |
Why?
|
| Germ-Line Mutation | 12 | 2019 | 1788 | 0.850 |
Why?
|
| Multigene Family | 8 | 2020 | 1102 | 0.840 |
Why?
|
| Quantitative Trait, Heritable | 15 | 2019 | 544 | 0.830 |
Why?
|
| Gene Deletion | 7 | 2017 | 2751 | 0.820 |
Why?
|
| Genetic Diseases, Inborn | 10 | 2021 | 587 | 0.800 |
Why?
|
| Pedigree | 48 | 2021 | 4644 | 0.790 |
Why?
|
| Intestinal Neoplasms | 1 | 2023 | 319 | 0.760 |
Why?
|
| Exons | 17 | 2020 | 2437 | 0.720 |
Why?
|
| RNA Splice Sites | 4 | 2018 | 209 | 0.700 |
Why?
|
| Computational Biology | 19 | 2020 | 3521 | 0.690 |
Why?
|
| Databases, Nucleic Acid | 6 | 2018 | 211 | 0.680 |
Why?
|
| Heterozygote | 30 | 2023 | 2804 | 0.660 |
Why?
|
| Genes, Recessive | 5 | 2023 | 641 | 0.650 |
Why?
|
| Proteins | 17 | 2023 | 6103 | 0.630 |
Why?
|
| Homozygote | 22 | 2023 | 1785 | 0.620 |
Why?
|
| Calcium Channels | 2 | 2020 | 622 | 0.620 |
Why?
|
| Minisatellite Repeats | 4 | 2013 | 165 | 0.620 |
Why?
|
| Biological Specimen Banks | 9 | 2023 | 711 | 0.600 |
Why?
|
| RNA Splicing | 4 | 2018 | 907 | 0.600 |
Why?
|
| Major Histocompatibility Complex | 12 | 2021 | 936 | 0.590 |
Why?
|
| Neuroendocrine Tumors | 1 | 2023 | 594 | 0.590 |
Why?
|
| Founder Effect | 9 | 2014 | 189 | 0.580 |
Why?
|
| Polymorphism, Genetic | 30 | 2018 | 4328 | 0.580 |
Why?
|
| Bipolar Disorder | 18 | 2023 | 5027 | 0.580 |
Why?
|
| Databases, Genetic | 17 | 2023 | 1783 | 0.560 |
Why?
|
| Female | 281 | 2024 | 380194 | 0.560 |
Why?
|
| Cation Transport Proteins | 4 | 2020 | 327 | 0.560 |
Why?
|
| Male | 252 | 2023 | 350118 | 0.560 |
Why?
|
| Alternative Splicing | 4 | 2018 | 1117 | 0.550 |
Why?
|
| Mental Disorders | 13 | 2020 | 6600 | 0.550 |
Why?
|
| Meta-Analysis as Topic | 12 | 2023 | 1344 | 0.550 |
Why?
|
| Algorithms | 28 | 2024 | 13881 | 0.540 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1086 | 0.540 |
Why?
|
| Nucleotides | 2 | 2018 | 464 | 0.530 |
Why?
|
| Sequence Deletion | 12 | 2020 | 1526 | 0.520 |
Why?
|
| Carrier Proteins | 22 | 2023 | 5021 | 0.520 |
Why?
|
| Base Sequence | 39 | 2016 | 12797 | 0.510 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 7 | 0.510 |
Why?
|
| Genetic Testing | 21 | 2023 | 3444 | 0.510 |
Why?
|
| Rare Diseases | 3 | 2020 | 553 | 0.510 |
Why?
|
| Gene Expression Regulation | 24 | 2023 | 12072 | 0.500 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1708 | 0.500 |
Why?
|
| High-Throughput Nucleotide Sequencing | 14 | 2023 | 3597 | 0.500 |
Why?
|
| DNA Mutational Analysis | 21 | 2021 | 4186 | 0.480 |
Why?
|
| Genes | 5 | 2017 | 1893 | 0.470 |
Why?
|
| Genes, Essential | 3 | 2020 | 183 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 5 | 11 | 2009 | 403 | 0.450 |
Why?
|
| Membrane Proteins | 19 | 2020 | 7880 | 0.450 |
Why?
|
| Gram-Positive Cocci | 4 | 2000 | 9 | 0.440 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2019 | 1861 | 0.440 |
Why?
|
| Lod Score | 26 | 2014 | 614 | 0.430 |
Why?
|
| DiGeorge Syndrome | 3 | 2022 | 177 | 0.430 |
Why?
|
| Calcium Channels, L-Type | 2 | 2011 | 240 | 0.430 |
Why?
|
| Developmental Disabilities | 3 | 2020 | 1456 | 0.430 |
Why?
|
| Penetrance | 5 | 2020 | 381 | 0.430 |
Why?
|
| Risk Factors | 78 | 2023 | 72290 | 0.420 |
Why?
|
| Chromosomes, Human | 9 | 2020 | 457 | 0.410 |
Why?
|
| Gene Dosage | 10 | 2016 | 1252 | 0.410 |
Why?
|
| Epilepsies, Partial | 3 | 2020 | 436 | 0.410 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.410 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 684 | 0.410 |
Why?
|
| Selection, Genetic | 9 | 2023 | 914 | 0.400 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 168 | 0.400 |
Why?
|
| Phylogeny | 10 | 2022 | 2803 | 0.400 |
Why?
|
| Autoimmune Diseases | 7 | 2014 | 2133 | 0.400 |
Why?
|
| Microsatellite Repeats | 16 | 2015 | 802 | 0.390 |
Why?
|
| Manganese | 3 | 2020 | 408 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 20 | 2015 | 3920 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 12 | 10 | 2009 | 462 | 0.380 |
Why?
|
| CARD Signaling Adaptor Proteins | 4 | 2017 | 156 | 0.380 |
Why?
|
| Complement C3b Inactivator Proteins | 1 | 2010 | 17 | 0.380 |
Why?
|
| Demography | 4 | 2020 | 1656 | 0.370 |
Why?
|
| Chromosomes, Human, X | 4 | 2021 | 296 | 0.370 |
Why?
|
| Multiple Sclerosis | 13 | 2015 | 3079 | 0.370 |
Why?
|
| DNA-Binding Proteins | 13 | 2016 | 9648 | 0.360 |
Why?
|
| Chromosomes, Mammalian | 7 | 2022 | 151 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 6 | 8 | 2009 | 380 | 0.360 |
Why?
|
| Radioactive Waste | 2 | 2000 | 8 | 0.350 |
Why?
|
| HLA-A Antigens | 4 | 2019 | 231 | 0.350 |
Why?
|
| Salmonella Infections | 3 | 2016 | 173 | 0.350 |
Why?
|
| Allelic Imbalance | 3 | 2019 | 77 | 0.350 |
Why?
|
| Nuclear Proteins | 9 | 2023 | 5853 | 0.350 |
Why?
|
| Sequence Alignment | 8 | 2014 | 2256 | 0.350 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2023 | 1222 | 0.340 |
Why?
|
| DNA | 14 | 2023 | 7301 | 0.340 |
Why?
|
| Complement Factor I | 3 | 2015 | 14 | 0.330 |
Why?
|
| Animals | 97 | 2024 | 168757 | 0.330 |
Why?
|
| Transcription Factors | 22 | 2021 | 12208 | 0.330 |
Why?
|
| Micrococcus | 2 | 1999 | 13 | 0.330 |
Why?
|
| HLA Antigens | 7 | 2021 | 1381 | 0.330 |
Why?
|
| Genetic Pleiotropy | 5 | 2021 | 182 | 0.330 |
Why?
|
| Population Groups | 4 | 2010 | 209 | 0.330 |
Why?
|
| Adult | 117 | 2023 | 214055 | 0.320 |
Why?
|
| Mucin-1 | 1 | 2013 | 543 | 0.320 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1341 | 0.310 |
Why?
|
| Human Genome Project | 5 | 2017 | 193 | 0.310 |
Why?
|
| Mice | 63 | 2024 | 81183 | 0.310 |
Why?
|
| Cytokine Receptor Common beta Subunit | 2 | 2019 | 22 | 0.310 |
Why?
|
| Computer Simulation | 21 | 2016 | 6196 | 0.310 |
Why?
|
| Genetic Techniques | 2 | 2008 | 435 | 0.310 |
Why?
|
| Epilepsy, Generalized | 2 | 2020 | 174 | 0.310 |
Why?
|
| Glaucoma | 3 | 2023 | 1159 | 0.310 |
Why?
|
| Membrane Glycoproteins | 6 | 2012 | 3768 | 0.310 |
Why?
|
| Open Reading Frames | 6 | 2018 | 810 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 2 | 6 | 2016 | 326 | 0.300 |
Why?
|
| Epilepsy | 6 | 2020 | 3310 | 0.300 |
Why?
|
| Genetic Drift | 2 | 2019 | 43 | 0.300 |
Why?
|
| Population | 3 | 2017 | 142 | 0.300 |
Why?
|
| Cohort Studies | 47 | 2021 | 40561 | 0.300 |
Why?
|
| Molecular Sequence Data | 40 | 2014 | 18111 | 0.300 |
Why?
|
| Amino Acid Substitution | 10 | 2020 | 1791 | 0.290 |
Why?
|
| Autophagy | 9 | 2018 | 1300 | 0.290 |
Why?
|
| Intestines | 6 | 2021 | 1924 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 8 | 2019 | 3712 | 0.280 |
Why?
|
| Receptors, Interleukin | 4 | 2013 | 245 | 0.280 |
Why?
|
| Geography | 6 | 2021 | 669 | 0.280 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1423 | 0.280 |
Why?
|
| Chromosome Aberrations | 6 | 2021 | 1813 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 8 | 5 | 2019 | 460 | 0.280 |
Why?
|
| Sialyltransferases | 3 | 2018 | 75 | 0.270 |
Why?
|
| Codon, Nonsense | 3 | 2019 | 281 | 0.270 |
Why?
|
| Middle Aged | 109 | 2023 | 213383 | 0.270 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2023 | 706 | 0.270 |
Why?
|
| Data Interpretation, Statistical | 5 | 2011 | 2716 | 0.270 |
Why?
|
| Models, Statistical | 8 | 2015 | 5102 | 0.260 |
Why?
|
| Evolution, Molecular | 7 | 2022 | 1940 | 0.260 |
Why?
|
| Inheritance Patterns | 6 | 2015 | 340 | 0.260 |
Why?
|
| Lactoferrin | 1 | 2006 | 97 | 0.260 |
Why?
|
| Reproducibility of Results | 28 | 2022 | 19905 | 0.260 |
Why?
|
| Blood Proteins | 1 | 2010 | 1124 | 0.260 |
Why?
|
| Family | 16 | 2020 | 3147 | 0.260 |
Why?
|
| Genetic Structures | 2 | 2022 | 12 | 0.260 |
Why?
|
| Physical Chromosome Mapping | 7 | 2020 | 183 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 8 | 2021 | 4462 | 0.250 |
Why?
|
| Denmark | 7 | 2020 | 738 | 0.250 |
Why?
|
| User-Computer Interface | 4 | 2019 | 1431 | 0.250 |
Why?
|
| Cholesterol, HDL | 7 | 2013 | 1814 | 0.250 |
Why?
|
| Mitochondrial Proteins | 4 | 2020 | 996 | 0.250 |
Why?
|
| Synteny | 3 | 2022 | 79 | 0.250 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2019 | 903 | 0.250 |
Why?
|
| Cardiovascular Diseases | 10 | 2023 | 15165 | 0.250 |
Why?
|
| Longevity | 6 | 2020 | 1070 | 0.250 |
Why?
|
| Chromosomes | 6 | 2023 | 596 | 0.240 |
Why?
|
| Molecular Epidemiology | 4 | 2022 | 468 | 0.240 |
Why?
|
| Trout | 1 | 2023 | 18 | 0.240 |
Why?
|
| Weight Loss | 3 | 2013 | 2622 | 0.240 |
Why?
|
| Postprandial Period | 2 | 2017 | 292 | 0.240 |
Why?
|
| Inbreeding | 2 | 2022 | 49 | 0.240 |
Why?
|
| Ixodes | 1 | 2024 | 39 | 0.240 |
Why?
|
| Consanguinity | 7 | 2020 | 454 | 0.240 |
Why?
|
| Heteroptera | 1 | 2023 | 2 | 0.240 |
Why?
|
| Serine Endopeptidases | 4 | 2021 | 1072 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 10 | 5 | 2021 | 287 | 0.230 |
Why?
|
| Internet | 7 | 2020 | 3064 | 0.230 |
Why?
|
| Pyrophosphatases | 2 | 2019 | 137 | 0.230 |
Why?
|
| Insulin | 9 | 2017 | 6580 | 0.230 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 6487 | 0.230 |
Why?
|
| Recombination, Genetic | 8 | 2009 | 1586 | 0.230 |
Why?
|
| Genetic Heterogeneity | 7 | 2021 | 733 | 0.230 |
Why?
|
| Genes, BRCA1 | 5 | 2009 | 781 | 0.230 |
Why?
|
| HLA-B Antigens | 3 | 2019 | 353 | 0.230 |
Why?
|
| Africa | 4 | 2021 | 673 | 0.230 |
Why?
|
| Migraine without Aura | 2 | 2018 | 83 | 0.230 |
Why?
|
| Organizational Policy | 1 | 2006 | 429 | 0.220 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2023 | 27 | 0.220 |
Why?
|
| Lipase | 4 | 2018 | 314 | 0.220 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6365 | 0.220 |
Why?
|
| Genome, Bacterial | 4 | 2001 | 760 | 0.220 |
Why?
|
| Alzheimer Disease | 6 | 2018 | 8037 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2013 | 373 | 0.220 |
Why?
|
| Transcription, Genetic | 7 | 2020 | 7722 | 0.220 |
Why?
|
| Lipids | 5 | 2021 | 3305 | 0.210 |
Why?
|
| Colitis | 3 | 2022 | 1170 | 0.210 |
Why?
|
| Sequence Homology | 2 | 2020 | 203 | 0.210 |
Why?
|
| Cattle | 2 | 2022 | 3922 | 0.210 |
Why?
|
| Likelihood Functions | 7 | 2014 | 1005 | 0.210 |
Why?
|
| Odds Ratio | 17 | 2018 | 9849 | 0.210 |
Why?
|
| Breast Neoplasms | 22 | 2020 | 20822 | 0.210 |
Why?
|
| Borrelia burgdorferi | 1 | 2024 | 180 | 0.210 |
Why?
|
| Child | 49 | 2023 | 77709 | 0.210 |
Why?
|
| Phosphoproteins | 5 | 2018 | 2440 | 0.210 |
Why?
|
| Emigration and Immigration | 2 | 2020 | 404 | 0.210 |
Why?
|
| Point Mutation | 6 | 2015 | 1623 | 0.210 |
Why?
|
| Age of Onset | 13 | 2020 | 3271 | 0.210 |
Why?
|
| Protein Conformation | 6 | 2020 | 4011 | 0.210 |
Why?
|
| Attitude to Health | 3 | 2008 | 2052 | 0.210 |
Why?
|
| Community Health Nursing | 1 | 2001 | 24 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 16 | 4 | 2015 | 354 | 0.200 |
Why?
|
| Otosclerosis | 1 | 2023 | 110 | 0.200 |
Why?
|
| Biostatistics | 2 | 2020 | 162 | 0.200 |
Why?
|
| Pouchitis | 1 | 2022 | 62 | 0.200 |
Why?
|
| Pharyngeal Diseases | 1 | 2023 | 133 | 0.200 |
Why?
|
| Interferon Regulatory Factors | 3 | 2009 | 270 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 106 | 0.200 |
Why?
|
| Low Tension Glaucoma | 1 | 2021 | 22 | 0.200 |
Why?
|
| Chromosomes, Bacterial | 5 | 2001 | 282 | 0.200 |
Why?
|
| Antithrombin III | 3 | 1996 | 128 | 0.200 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 528 | 0.200 |
Why?
|
| History, 21st Century | 3 | 2018 | 1534 | 0.200 |
Why?
|
| INDEL Mutation | 3 | 2018 | 279 | 0.200 |
Why?
|
| Nuclear Family | 9 | 2007 | 318 | 0.200 |
Why?
|
| RNA, Messenger | 15 | 2022 | 13033 | 0.200 |
Why?
|
| Obesity | 9 | 2020 | 12745 | 0.200 |
Why?
|
| Migraine Disorders | 5 | 2018 | 1620 | 0.200 |
Why?
|
| Myosins | 3 | 2009 | 409 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2915 | 0.200 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2021 | 41 | 0.190 |
Why?
|
| Pre-Eclampsia | 2 | 2023 | 1200 | 0.190 |
Why?
|
| Radiology Information Systems | 3 | 2011 | 523 | 0.190 |
Why?
|
| Neoplasms | 9 | 2020 | 21683 | 0.190 |
Why?
|
| Geographic Atrophy | 2 | 2012 | 66 | 0.190 |
Why?
|
| Oxidoreductases | 2 | 2020 | 424 | 0.190 |
Why?
|
| Dyslipidemias | 2 | 2021 | 849 | 0.190 |
Why?
|
| Risk | 17 | 2020 | 9687 | 0.190 |
Why?
|
| Aging | 7 | 2021 | 8664 | 0.190 |
Why?
|
| Sample Size | 8 | 2020 | 845 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2011 | 535 | 0.190 |
Why?
|
| Brain | 16 | 2023 | 26385 | 0.190 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1352 | 0.190 |
Why?
|
| Exfoliation Syndrome | 1 | 2021 | 110 | 0.180 |
Why?
|
| Complement C3 | 3 | 2013 | 461 | 0.180 |
Why?
|
| Parturition | 2 | 2018 | 441 | 0.180 |
Why?
|
| Professional Autonomy | 1 | 2001 | 177 | 0.180 |
Why?
|
| Peptide Hormones | 1 | 2021 | 134 | 0.180 |
Why?
|
| Antithrombin III Deficiency | 2 | 1998 | 30 | 0.180 |
Why?
|
| Waste Management | 1 | 2000 | 19 | 0.180 |
Why?
|
| Gene Expression | 10 | 2018 | 7799 | 0.180 |
Why?
|
| Lymphocytes | 6 | 2020 | 2617 | 0.180 |
Why?
|
| Safety Management | 1 | 2006 | 783 | 0.180 |
Why?
|
| Psychotic Disorders | 4 | 2023 | 3046 | 0.180 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 210 | 0.180 |
Why?
|
| Ocular Hypertension | 1 | 2021 | 198 | 0.180 |
Why?
|
| Aged | 71 | 2021 | 163280 | 0.180 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2014 | 186 | 0.180 |
Why?
|
| Amino Acid Sequence | 20 | 2020 | 13815 | 0.180 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2021 | 581 | 0.170 |
Why?
|
| Repressor Proteins | 6 | 2020 | 3023 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2008 | 2104 | 0.170 |
Why?
|
| Fasting | 6 | 2017 | 1593 | 0.170 |
Why?
|
| Nurse's Role | 1 | 2001 | 209 | 0.170 |
Why?
|
| History, 20th Century | 3 | 2018 | 2740 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2023 | 371 | 0.170 |
Why?
|
| Sequence Tagged Sites | 4 | 2006 | 94 | 0.170 |
Why?
|
| Protein Isoforms | 5 | 2018 | 1730 | 0.170 |
Why?
|
| Apolipoprotein E4 | 1 | 2023 | 668 | 0.170 |
Why?
|
| Blood Glucose | 7 | 2011 | 6256 | 0.170 |
Why?
|
| BRCA2 Protein | 7 | 2011 | 794 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2012 | 2849 | 0.170 |
Why?
|
| Interleukins | 2 | 2017 | 791 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 3 | 2020 | 1477 | 0.170 |
Why?
|
| Cholesterol, LDL | 6 | 2020 | 2356 | 0.170 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2022 | 967 | 0.170 |
Why?
|
| Paternal Age | 1 | 2019 | 84 | 0.170 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2021 | 159 | 0.170 |
Why?
|
| Cell Line | 14 | 2022 | 15997 | 0.170 |
Why?
|
| Chromosome Deletion | 7 | 2015 | 1401 | 0.170 |
Why?
|
| Triglycerides | 5 | 2021 | 2454 | 0.170 |
Why?
|
| Europe | 10 | 2020 | 3339 | 0.170 |
Why?
|
| Radioactive Pollutants | 1 | 1998 | 12 | 0.170 |
Why?
|
| Insulin Resistance | 5 | 2017 | 3864 | 0.170 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 116 | 0.170 |
Why?
|
| Genes, BRCA2 | 3 | 2009 | 618 | 0.170 |
Why?
|
| Neurobiology | 1 | 2020 | 121 | 0.170 |
Why?
|
| Adolescent | 43 | 2021 | 85781 | 0.160 |
Why?
|
| Guanylate Cyclase | 2 | 2012 | 201 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2019 | 1414 | 0.160 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 110 | 0.160 |
Why?
|
| Carbamazepine | 1 | 2019 | 229 | 0.160 |
Why?
|
| Apolipoproteins E | 4 | 2018 | 1438 | 0.160 |
Why?
|
| Family Health | 8 | 2017 | 1282 | 0.160 |
Why?
|
| Dietary Carbohydrates | 1 | 2003 | 906 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2009 | 658 | 0.160 |
Why?
|
| BRCA1 Protein | 7 | 2020 | 1149 | 0.160 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 328 | 0.160 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 74 | 0.160 |
Why?
|
| Thyrotropin | 2 | 2020 | 849 | 0.160 |
Why?
|
| Choroidal Neovascularization | 2 | 2012 | 343 | 0.160 |
Why?
|
| Biological Psychiatry | 1 | 2017 | 25 | 0.160 |
Why?
|
| Gene Flow | 1 | 2018 | 79 | 0.160 |
Why?
|
| Tourette Syndrome | 1 | 2021 | 379 | 0.160 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 658 | 0.160 |
Why?
|
| Lyme Disease | 1 | 2024 | 621 | 0.160 |
Why?
|
| Immunity, Innate | 4 | 2013 | 2958 | 0.160 |
Why?
|
| Radiation Tolerance | 6 | 2000 | 486 | 0.160 |
Why?
|
| Heat-Shock Proteins | 2 | 2019 | 822 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2008 | 374 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 1270 | 0.150 |
Why?
|
| Adherens Junctions | 1 | 2018 | 90 | 0.150 |
Why?
|
| Population Density | 1 | 2018 | 196 | 0.150 |
Why?
|
| Smad3 Protein | 2 | 2017 | 180 | 0.150 |
Why?
|
| Mesalamine | 1 | 2018 | 136 | 0.150 |
Why?
|
| Child, Preschool | 24 | 2020 | 41006 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2022 | 643 | 0.150 |
Why?
|
| Adaptive Immunity | 2 | 2013 | 713 | 0.150 |
Why?
|
| Mercury | 1 | 2000 | 285 | 0.150 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 695 | 0.150 |
Why?
|
| Hexosyltransferases | 1 | 2016 | 53 | 0.150 |
Why?
|
| Chymotrypsin | 1 | 2016 | 149 | 0.150 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 165 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2015 | 1157 | 0.150 |
Why?
|
| Conserved Sequence | 7 | 2018 | 1202 | 0.150 |
Why?
|
| Nod2 Signaling Adaptor Protein | 3 | 2015 | 87 | 0.150 |
Why?
|
| Thromboembolism | 2 | 2020 | 986 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.140 |
Why?
|
| Genetic Engineering | 2 | 2000 | 951 | 0.140 |
Why?
|
| Genetic Counseling | 3 | 1999 | 600 | 0.140 |
Why?
|
| Bruch Membrane | 1 | 2016 | 64 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2011 | 560 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 4554 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 895 | 0.140 |
Why?
|
| Rec A Recombinases | 1 | 1996 | 51 | 0.140 |
Why?
|
| Disease Susceptibility | 8 | 2019 | 1782 | 0.140 |
Why?
|
| Specialization | 1 | 2001 | 777 | 0.140 |
Why?
|
| Celiac Disease | 4 | 2011 | 785 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1997 | 245 | 0.140 |
Why?
|
| Retinal Drusen | 1 | 2016 | 66 | 0.140 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3647 | 0.140 |
Why?
|
| Sodium | 2 | 2020 | 1623 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 954 | 0.140 |
Why?
|
| Salmonella enterica | 1 | 2016 | 75 | 0.140 |
Why?
|
| Risk Assessment | 15 | 2023 | 23338 | 0.140 |
Why?
|
| Species Specificity | 6 | 2014 | 2478 | 0.140 |
Why?
|
| Plasma | 1 | 2019 | 575 | 0.140 |
Why?
|
| Body Height | 2 | 2019 | 1577 | 0.140 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 2 | 2019 | 142 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2019 | 367 | 0.140 |
Why?
|
| Genes, Lethal | 1 | 2016 | 242 | 0.140 |
Why?
|
| Agranulocytosis | 2 | 2014 | 101 | 0.140 |
Why?
|
| Gene Rearrangement | 2 | 2012 | 1179 | 0.140 |
Why?
|
| Salmonella typhimurium | 2 | 2016 | 351 | 0.140 |
Why?
|
| Markov Chains | 3 | 2012 | 969 | 0.140 |
Why?
|
| Poisson Distribution | 2 | 2020 | 513 | 0.140 |
Why?
|
| Consensus Sequence | 2 | 2014 | 377 | 0.140 |
Why?
|
| Radiology Department, Hospital | 2 | 2011 | 412 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 497 | 0.130 |
Why?
|
| Candidiasis, Invasive | 1 | 2015 | 22 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 670 | 0.130 |
Why?
|
| Migraine with Aura | 1 | 2018 | 203 | 0.130 |
Why?
|
| Ovarian Neoplasms | 10 | 2004 | 4838 | 0.130 |
Why?
|
| Neutrophils | 2 | 2019 | 3719 | 0.130 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 177 | 0.130 |
Why?
|
| DNA Transposable Elements | 1 | 1999 | 748 | 0.130 |
Why?
|
| Receptors, Endothelin | 1 | 2015 | 58 | 0.130 |
Why?
|
| Communication Disorders | 1 | 2016 | 51 | 0.130 |
Why?
|
| Gene Expression Profiling | 13 | 2019 | 9438 | 0.130 |
Why?
|
| Potassium Channels | 2 | 2012 | 563 | 0.130 |
Why?
|
| Lysosomes | 2 | 2022 | 893 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2009 | 322 | 0.130 |
Why?
|
| Heredity | 1 | 2016 | 154 | 0.130 |
Why?
|
| Eye Neoplasms | 1 | 2017 | 313 | 0.130 |
Why?
|
| Skin Pigmentation | 1 | 2017 | 282 | 0.130 |
Why?
|
| Ubiquitination | 3 | 2018 | 1012 | 0.130 |
Why?
|
| Lectins, C-Type | 2 | 2017 | 588 | 0.130 |
Why?
|
| Receptors, Mitogen | 1 | 2015 | 62 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2022 | 686 | 0.130 |
Why?
|
| Receptors, Angiotensin | 1 | 2015 | 142 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 19 | 2018 | 21827 | 0.130 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2016 | 226 | 0.130 |
Why?
|
| Contactins | 1 | 2015 | 21 | 0.130 |
Why?
|
| Frameshift Mutation | 2 | 2016 | 399 | 0.130 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2016 | 117 | 0.130 |
Why?
|
| Chromatin | 5 | 2017 | 2934 | 0.130 |
Why?
|
| Complement C4 | 1 | 2016 | 257 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2009 | 1018 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2018 | 321 | 0.130 |
Why?
|
| Zebrafish | 6 | 2019 | 2994 | 0.130 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2014 | 11 | 0.130 |
Why?
|
| Principal Component Analysis | 5 | 2019 | 940 | 0.130 |
Why?
|
| Marijuana Abuse | 1 | 2019 | 403 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2759 | 0.130 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 513 | 0.130 |
Why?
|
| Seizures | 2 | 2020 | 2859 | 0.130 |
Why?
|
| Research | 1 | 2024 | 1999 | 0.130 |
Why?
|
| Shaw Potassium Channels | 1 | 2014 | 20 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 742 | 0.130 |
Why?
|
| Genes, MHC Class I | 2 | 2016 | 258 | 0.130 |
Why?
|
| Muscle Proteins | 3 | 2014 | 1159 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2020 | 2916 | 0.130 |
Why?
|
| Prion Diseases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Chromosome Breakage | 2 | 2012 | 173 | 0.130 |
Why?
|
| Chaperonins | 1 | 2014 | 62 | 0.120 |
Why?
|
| Aged, 80 and over | 28 | 2021 | 57776 | 0.120 |
Why?
|
| Cognition Disorders | 3 | 2014 | 4043 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 606 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2008 | 565 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 14 | 2011 | 6171 | 0.120 |
Why?
|
| Myopathies, Nemaline | 1 | 2014 | 72 | 0.120 |
Why?
|
| Genetic Code | 1 | 2014 | 154 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2004 | 417 | 0.120 |
Why?
|
| GTP-Binding Proteins | 2 | 2009 | 970 | 0.120 |
Why?
|
| Lipoprotein(a) | 1 | 2018 | 435 | 0.120 |
Why?
|
| Complement C9 | 1 | 2013 | 16 | 0.120 |
Why?
|
| Linear Models | 3 | 2020 | 5952 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 552 | 0.120 |
Why?
|
| Epithelial Cells | 5 | 2023 | 3690 | 0.120 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 1184 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2020 | 727 | 0.120 |
Why?
|
| Myofibrils | 1 | 2014 | 146 | 0.120 |
Why?
|
| Bayes Theorem | 5 | 2023 | 2309 | 0.120 |
Why?
|
| Societies, Scientific | 1 | 2015 | 220 | 0.120 |
Why?
|
| Logistic Models | 9 | 2019 | 13408 | 0.120 |
Why?
|
| Paneth Cells | 1 | 2014 | 99 | 0.120 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 323 | 0.120 |
Why?
|
| Intestinal Mucosa | 6 | 2023 | 3036 | 0.120 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 247 | 0.120 |
Why?
|
| Hypertension | 5 | 2020 | 8480 | 0.120 |
Why?
|
| Regression Analysis | 6 | 2015 | 6459 | 0.120 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2007 | 450 | 0.120 |
Why?
|
| Neoplasm Proteins | 8 | 2011 | 3703 | 0.120 |
Why?
|
| Gastric Bypass | 2 | 2013 | 812 | 0.120 |
Why?
|
| HLA-DR Antigens | 4 | 2011 | 645 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 505 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2008 | 323 | 0.110 |
Why?
|
| Gamma Rays | 4 | 2011 | 320 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2018 | 351 | 0.110 |
Why?
|
| Environment | 5 | 2012 | 1124 | 0.110 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2013 | 76 | 0.110 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2013 | 102 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2018 | 764 | 0.110 |
Why?
|
| Calcium | 6 | 2006 | 5756 | 0.110 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2012 | 22 | 0.110 |
Why?
|
| Salmonella | 2 | 2015 | 129 | 0.110 |
Why?
|
| Young Adult | 19 | 2021 | 56430 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5867 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4420 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2021 | 4266 | 0.110 |
Why?
|
| Long QT Syndrome | 2 | 2014 | 453 | 0.110 |
Why?
|
| Hand Deformities, Congenital | 2 | 2012 | 146 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3870 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2010 | 147 | 0.110 |
Why?
|
| Alopecia Areata | 1 | 2015 | 107 | 0.110 |
Why?
|
| Heart | 4 | 2012 | 4467 | 0.110 |
Why?
|
| Expressed Sequence Tags | 1 | 2013 | 255 | 0.110 |
Why?
|
| Stevens-Johnson Syndrome | 2 | 2019 | 280 | 0.110 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 115 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2013 | 100 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2015 | 288 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2014 | 458 | 0.110 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 871 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2021 | 880 | 0.110 |
Why?
|
| Fetal Hemoglobin | 1 | 2015 | 341 | 0.110 |
Why?
|
| Micronesia | 5 | 2010 | 43 | 0.110 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2016 | 357 | 0.110 |
Why?
|
| Protein Interaction Mapping | 2 | 2015 | 627 | 0.110 |
Why?
|
| Diarrhea, Infantile | 1 | 2012 | 109 | 0.110 |
Why?
|
| Hypoparathyroidism | 1 | 2013 | 120 | 0.110 |
Why?
|
| Crosses, Genetic | 9 | 2010 | 791 | 0.110 |
Why?
|
| Introns | 7 | 2015 | 991 | 0.110 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2017 | 906 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2017 | 1349 | 0.100 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3589 | 0.100 |
Why?
|
| Immunity | 1 | 2018 | 1012 | 0.100 |
Why?
|
| HLA-DQ Antigens | 3 | 2011 | 210 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 243 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 509 | 0.100 |
Why?
|
| Epigenomics | 2 | 2014 | 903 | 0.100 |
Why?
|
| Waist-Hip Ratio | 3 | 2020 | 517 | 0.100 |
Why?
|
| Menopause, Premature | 1 | 2013 | 132 | 0.100 |
Why?
|
| Fatty Acid Desaturases | 1 | 2012 | 102 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2017 | 310 | 0.100 |
Why?
|
| DNA Repair | 4 | 2016 | 2046 | 0.100 |
Why?
|
| Siblings | 8 | 2012 | 854 | 0.100 |
Why?
|
| Exercise | 1 | 2008 | 5615 | 0.100 |
Why?
|
| Collagen Type X | 1 | 2011 | 16 | 0.100 |
Why?
|
| Bacillus megaterium | 1 | 2011 | 20 | 0.100 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 222 | 0.100 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2021 | 1444 | 0.100 |
Why?
|
| Cytosine | 1 | 2013 | 216 | 0.100 |
Why?
|
| Prevalence | 9 | 2020 | 15226 | 0.100 |
Why?
|
| Inflammation | 5 | 2023 | 10638 | 0.100 |
Why?
|
| Peroxides | 1 | 1991 | 74 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2015 | 270 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 547 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 498 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2015 | 894 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2727 | 0.100 |
Why?
|
| Interleukin-18 Receptor beta Subunit | 1 | 2011 | 3 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 2012 | 206 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1170 | 0.100 |
Why?
|
| Behavior | 1 | 2014 | 561 | 0.100 |
Why?
|
| Polychondritis, Relapsing | 1 | 2011 | 28 | 0.100 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2011 | 30 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2017 | 3528 | 0.100 |
Why?
|
| Optic Disk Drusen | 1 | 2011 | 35 | 0.100 |
Why?
|
| Oxidants | 1 | 1991 | 164 | 0.100 |
Why?
|
| Blood Cells | 1 | 2013 | 309 | 0.100 |
Why?
|
| Colon | 1 | 2019 | 1772 | 0.100 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 964 | 0.100 |
Why?
|
| Cloning, Molecular | 5 | 2008 | 4320 | 0.100 |
Why?
|
| Mycobacterium | 1 | 2012 | 249 | 0.100 |
Why?
|
| Immune System Diseases | 2 | 2013 | 262 | 0.100 |
Why?
|
| Clozapine | 1 | 2014 | 498 | 0.100 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2010 | 11 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2016 | 859 | 0.100 |
Why?
|
| Hydro-Lyases | 1 | 2011 | 94 | 0.100 |
Why?
|
| Ataxia | 1 | 2013 | 304 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 2020 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1736 | 0.100 |
Why?
|
| Cluster Analysis | 6 | 2020 | 2715 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.090 |
Why?
|
| Software Design | 1 | 2011 | 176 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2011 | 51 | 0.090 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 3508 | 0.090 |
Why?
|
| Melanoma | 3 | 2017 | 5510 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2012 | 227 | 0.090 |
Why?
|
| Asthma | 4 | 2023 | 6011 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 933 | 0.090 |
Why?
|
| Anorexia Nervosa | 2 | 2017 | 1286 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 884 | 0.090 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2016 | 969 | 0.090 |
Why?
|
| HEK293 Cells | 5 | 2021 | 4204 | 0.090 |
Why?
|
| Immune System | 2 | 2013 | 805 | 0.090 |
Why?
|
| Angiopoietins | 1 | 2010 | 80 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1058 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 1701 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2212 | 0.090 |
Why?
|
| Quebec | 3 | 2005 | 134 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2077 | 0.090 |
Why?
|
| Mice, Knockout | 9 | 2017 | 14557 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2017 | 2488 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2012 | 1832 | 0.090 |
Why?
|
| Myocardium | 5 | 2014 | 4776 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 457 | 0.090 |
Why?
|
| Floxacillin | 1 | 2009 | 4 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1863 | 0.090 |
Why?
|
| Polymorphism, Restriction Fragment Length | 6 | 2002 | 768 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2006 | 367 | 0.090 |
Why?
|
| Toluene | 2 | 2000 | 32 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2014 | 721 | 0.090 |
Why?
|
| Sterols | 1 | 2009 | 63 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2007 | 118 | 0.090 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2010 | 140 | 0.090 |
Why?
|
| Epistasis, Genetic | 2 | 2008 | 365 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 2010 | 58 | 0.090 |
Why?
|
| Arginine | 2 | 2010 | 944 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
| HeLa Cells | 5 | 2016 | 3128 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2010 | 293 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 445 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1563 | 0.080 |
Why?
|
| Genes, Dominant | 4 | 2015 | 880 | 0.080 |
Why?
|
| Receptors, GABA-A | 2 | 2020 | 627 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2018 | 1097 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 58 | 0.080 |
Why?
|
| Cadherins | 2 | 2010 | 907 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 153 | 0.080 |
Why?
|
| Synapses | 2 | 2016 | 1728 | 0.080 |
Why?
|
| Androgens | 1 | 2016 | 1281 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 478 | 0.080 |
Why?
|
| Information Management | 1 | 2009 | 101 | 0.080 |
Why?
|
| Models, Biological | 4 | 2011 | 9583 | 0.080 |
Why?
|
| North America | 3 | 2020 | 1249 | 0.080 |
Why?
|
| Ankyrins | 1 | 2008 | 128 | 0.080 |
Why?
|
| Dogs | 2 | 2005 | 3912 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.080 |
Why?
|
| Leuprolide | 4 | 1994 | 321 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 264 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2503 | 0.080 |
Why?
|
| Signal Transduction | 13 | 2023 | 23403 | 0.080 |
Why?
|
| Myosin Type V | 1 | 2008 | 34 | 0.080 |
Why?
|
| Germany | 3 | 2019 | 862 | 0.080 |
Why?
|
| Proteomics | 3 | 2020 | 3638 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 783 | 0.080 |
Why?
|
| Genes, Bacterial | 4 | 2001 | 1079 | 0.080 |
Why?
|
| Time Factors | 13 | 2020 | 40075 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 3386 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2114 | 0.080 |
Why?
|
| Vasodilation | 1 | 2012 | 944 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 720 | 0.080 |
Why?
|
| Antigens, CD | 4 | 2017 | 4026 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 731 | 0.080 |
Why?
|
| Zea mays | 1 | 2008 | 105 | 0.080 |
Why?
|
| Immunophenotyping | 1 | 2012 | 1880 | 0.080 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2007 | 52 | 0.080 |
Why?
|
| Body Mass Index | 8 | 2022 | 12720 | 0.080 |
Why?
|
| Registries | 6 | 2020 | 8089 | 0.080 |
Why?
|
| Parkinson Disease | 2 | 2020 | 2775 | 0.080 |
Why?
|
| Th17 Cells | 3 | 2022 | 766 | 0.080 |
Why?
|
| Rats | 12 | 2012 | 24260 | 0.080 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 759 | 0.080 |
Why?
|
| Eye Proteins | 2 | 2021 | 646 | 0.080 |
Why?
|
| Stomach | 2 | 2011 | 697 | 0.080 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 422 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2021 | 47 | 0.070 |
Why?
|
| Ion Transport | 1 | 2008 | 320 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2017 | 1591 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2020 | 5456 | 0.070 |
Why?
|
| DNA Methylation | 3 | 2020 | 4286 | 0.070 |
Why?
|
| Trans-Activators | 3 | 2007 | 2924 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2007 | 90 | 0.070 |
Why?
|
| Parthenogenesis | 1 | 2006 | 31 | 0.070 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2021 | 73 | 0.070 |
Why?
|
| Myocardial Infarction | 4 | 2017 | 11727 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2017 | 5686 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
| Educational Status | 3 | 2021 | 2540 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2282 | 0.070 |
Why?
|
| Endopeptidases | 1 | 1990 | 772 | 0.070 |
Why?
|
| Deafness | 1 | 2011 | 458 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 3336 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 94 | 0.070 |
Why?
|
| Cystic Fibrosis | 2 | 2002 | 1177 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2013 | 799 | 0.070 |
Why?
|
| Hot Temperature | 2 | 2011 | 1354 | 0.070 |
Why?
|
| Glycoproteins | 2 | 2021 | 2263 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2010 | 320 | 0.070 |
Why?
|
| Glucokinase | 1 | 2007 | 103 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2013 | 1124 | 0.070 |
Why?
|
| Homeodomain Proteins | 3 | 2021 | 2421 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 52 | 0.070 |
Why?
|
| Comorbidity | 5 | 2022 | 10388 | 0.070 |
Why?
|
| Cells, Cultured | 10 | 2016 | 19229 | 0.070 |
Why?
|
| Medical History Taking | 2 | 2008 | 783 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1996 | 2186 | 0.070 |
Why?
|
| Biometry | 2 | 2008 | 558 | 0.070 |
Why?
|
| Prognosis | 8 | 2020 | 29063 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 2 | 2020 | 418 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2009 | 525 | 0.070 |
Why?
|
| Family Relations | 1 | 2008 | 321 | 0.070 |
Why?
|
| H-2 Antigens | 1 | 2006 | 366 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 140 | 0.070 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 1294 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 414 | 0.070 |
Why?
|
| DNA, Bacterial | 4 | 2019 | 1465 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 262 | 0.070 |
Why?
|
| Osteochondrodysplasias | 2 | 2000 | 183 | 0.070 |
Why?
|
| Information Services | 1 | 2007 | 244 | 0.070 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 39050 | 0.070 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 484 | 0.070 |
Why?
|
| Insulysin | 1 | 2006 | 50 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 2 | 2000 | 862 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1100 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2021 | 2008 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 3 | 2017 | 944 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1416 | 0.070 |
Why?
|
| Matched-Pair Analysis | 4 | 2000 | 288 | 0.070 |
Why?
|
| Infant | 12 | 2019 | 35136 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2006 | 197 | 0.070 |
Why?
|
| Sex Factors | 5 | 2020 | 10397 | 0.070 |
Why?
|
| Arthritis | 1 | 2011 | 659 | 0.070 |
Why?
|
| Turner Syndrome | 1 | 2006 | 130 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 873 | 0.070 |
Why?
|
| Frontal Sinus | 1 | 2005 | 50 | 0.070 |
Why?
|
| Gene Library | 2 | 2023 | 1074 | 0.070 |
Why?
|
| Orientation | 1 | 2007 | 327 | 0.070 |
Why?
|
| Histocompatibility | 1 | 2006 | 330 | 0.070 |
Why?
|
| Plasmids | 5 | 2006 | 2307 | 0.070 |
Why?
|
| Glycosylation | 2 | 2020 | 1126 | 0.070 |
Why?
|
| Frontal Bone | 1 | 2005 | 105 | 0.070 |
Why?
|
| X Chromosome | 3 | 2012 | 814 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2009 | 1184 | 0.070 |
Why?
|
| Coronary Disease | 4 | 2017 | 6077 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2043 | 0.070 |
Why?
|
| Protein Binding | 6 | 2017 | 9386 | 0.060 |
Why?
|
| Ozone | 2 | 1999 | 469 | 0.060 |
Why?
|
| Macrophages | 4 | 2021 | 5655 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 5 | 2013 | 6386 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1607 | 0.060 |
Why?
|
| Contracture | 1 | 1987 | 223 | 0.060 |
Why?
|
| Organizational Case Studies | 1 | 2006 | 299 | 0.060 |
Why?
|
| Glucose | 4 | 2018 | 4397 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 494 | 0.060 |
Why?
|
| Mosaicism | 2 | 2021 | 441 | 0.060 |
Why?
|
| Diabetes Mellitus | 3 | 2017 | 5751 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2008 | 817 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 2278 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2008 | 1590 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2008 | 459 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 2 | 1996 | 210 | 0.060 |
Why?
|
| Statistics, Nonparametric | 4 | 2012 | 2886 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 142 | 0.060 |
Why?
|
| Binding Sites | 3 | 2018 | 6114 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2013 | 1580 | 0.060 |
Why?
|
| Cytokines | 4 | 2020 | 7322 | 0.060 |
Why?
|
| Placenta | 2 | 2024 | 1698 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2010 | 3206 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2004 | 160 | 0.060 |
Why?
|
| Antigens, Surface | 3 | 2022 | 1663 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 930 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2016 | 4042 | 0.060 |
Why?
|
| Cognition | 4 | 2023 | 6770 | 0.060 |
Why?
|
| Tuberculosis | 2 | 2008 | 1912 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2022 | 2557 | 0.060 |
Why?
|
| P-Selectin | 2 | 2011 | 600 | 0.060 |
Why?
|
| Reoperation | 1 | 2014 | 4201 | 0.060 |
Why?
|
| Mice, Congenic | 3 | 2008 | 99 | 0.060 |
Why?
|
| Programming Languages | 1 | 2004 | 133 | 0.060 |
Why?
|
| Depressive Disorder, Major | 4 | 2019 | 4644 | 0.060 |
Why?
|
| alpha-Macroglobulins | 1 | 2003 | 64 | 0.060 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2023 | 13 | 0.060 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 223 | 0.060 |
Why?
|
| Uterine Neoplasms | 4 | 1994 | 1513 | 0.060 |
Why?
|
| Leiomyoma | 3 | 1994 | 730 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 90 | 0.060 |
Why?
|
| Hippocampus | 1 | 2016 | 3675 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
| Th2 Cells | 2 | 2000 | 1061 | 0.060 |
Why?
|
| Prions | 2 | 2016 | 180 | 0.060 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2003 | 75 | 0.060 |
Why?
|
| Fibronectins | 1 | 2007 | 726 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 5708 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2014 | 2839 | 0.060 |
Why?
|
| von Willebrand Factor | 2 | 2000 | 669 | 0.060 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2004 | 150 | 0.060 |
Why?
|
| Estonia | 1 | 2023 | 53 | 0.060 |
Why?
|
| Ethosuximide | 1 | 1982 | 9 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 2268 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2005 | 526 | 0.060 |
Why?
|
| Genome, Plant | 1 | 2023 | 78 | 0.060 |
Why?
|
| Forecasting | 1 | 2012 | 2951 | 0.060 |
Why?
|
| Albinism | 1 | 2002 | 25 | 0.060 |
Why?
|
| Reference Values | 5 | 2008 | 4982 | 0.060 |
Why?
|
| Neck | 1 | 2007 | 697 | 0.060 |
Why?
|
| Sloths | 1 | 2022 | 3 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2009 | 1047 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 18029 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2018 | 1866 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 1005 | 0.060 |
Why?
|
| Genes, p16 | 1 | 2003 | 157 | 0.060 |
Why?
|
| Biological Evolution | 3 | 2005 | 1076 | 0.060 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 4584 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 473 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1364 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2022 | 57 | 0.050 |
Why?
|
| Monophenol Monooxygenase | 1 | 2002 | 69 | 0.050 |
Why?
|
| Neurofibroma | 1 | 2003 | 106 | 0.050 |
Why?
|
| Epilepsy, Absence | 1 | 1982 | 48 | 0.050 |
Why?
|
| Arabs | 1 | 2004 | 178 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1655 | 0.050 |
Why?
|
| Genes, abl | 1 | 2002 | 72 | 0.050 |
Why?
|
| Operon | 2 | 2001 | 363 | 0.050 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2012 | 1344 | 0.050 |
Why?
|
| Selection Bias | 2 | 2002 | 371 | 0.050 |
Why?
|
| Incidence | 6 | 2020 | 20947 | 0.050 |
Why?
|
| Albuminuria | 2 | 2014 | 682 | 0.050 |
Why?
|
| Antithrombins | 2 | 1998 | 304 | 0.050 |
Why?
|
| Drosophila melanogaster | 3 | 2006 | 1708 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2011 | 1210 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 686 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2009 | 2752 | 0.050 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Burkholderia cepacia | 1 | 2002 | 22 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1095 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2004 | 564 | 0.050 |
Why?
|
| Head | 1 | 2007 | 880 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 1999 | 437 | 0.050 |
Why?
|
| RNA Interference | 4 | 2018 | 2889 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2006 | 510 | 0.050 |
Why?
|
| Thrombosis | 1 | 1996 | 2968 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 942 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.050 |
Why?
|
| Life Style | 3 | 2012 | 3835 | 0.050 |
Why?
|
| Histones | 3 | 2018 | 2599 | 0.050 |
Why?
|
| Succimer | 1 | 1981 | 31 | 0.050 |
Why?
|
| Internationality | 3 | 2014 | 1003 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2455 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2009 | 1904 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2021 | 1364 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 169 | 0.050 |
Why?
|
| DNA, Ribosomal | 2 | 2019 | 290 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2010 | 2499 | 0.050 |
Why?
|
| Plasmacytoma | 1 | 2002 | 183 | 0.050 |
Why?
|
| Burkholderia Infections | 1 | 2002 | 44 | 0.050 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 522 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 927 | 0.050 |
Why?
|
| Receptors, Virus | 2 | 2020 | 648 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 46 | 0.050 |
Why?
|
| Estrogen Antagonists | 2 | 1998 | 152 | 0.050 |
Why?
|
| Gene Conversion | 1 | 2001 | 71 | 0.050 |
Why?
|
| Clostridium | 1 | 2001 | 98 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2020 | 2504 | 0.050 |
Why?
|
| Portugal | 3 | 2005 | 87 | 0.050 |
Why?
|
| Technetium | 1 | 1981 | 334 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1726 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2003 | 481 | 0.050 |
Why?
|
| Chromosome Inversion | 2 | 2012 | 127 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15076 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1114 | 0.050 |
Why?
|
| Serpin E2 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 3057 | 0.050 |
Why?
|
| Reference Standards | 2 | 2020 | 1025 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 1 | 2021 | 215 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 1213 | 0.050 |
Why?
|
| Weibel-Palade Bodies | 1 | 2000 | 19 | 0.050 |
Why?
|
| Ireland | 3 | 2008 | 161 | 0.050 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 1150 | 0.050 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 135 | 0.050 |
Why?
|
| Glycerol Kinase | 1 | 2000 | 16 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3462 | 0.050 |
Why?
|
| Access to Information | 1 | 2023 | 320 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2007 | 1533 | 0.050 |
Why?
|
| United States | 13 | 2020 | 69872 | 0.050 |
Why?
|
| Cell Differentiation | 5 | 2023 | 11483 | 0.050 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2020 | 69 | 0.050 |
Why?
|
| Counseling | 1 | 2008 | 1523 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 849 | 0.050 |
Why?
|
| Sweden | 3 | 2012 | 1345 | 0.050 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2020 | 65 | 0.050 |
Why?
|
| Thyroglobulin | 1 | 2020 | 114 | 0.050 |
Why?
|
| Goiter | 1 | 2020 | 87 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2007 | 2290 | 0.050 |
Why?
|
| Antiporters | 2 | 2007 | 277 | 0.050 |
Why?
|
| Transformation, Bacterial | 1 | 2000 | 78 | 0.050 |
Why?
|
| Leigh Disease | 1 | 2001 | 75 | 0.050 |
Why?
|
| Pregnancy | 5 | 2024 | 29144 | 0.050 |
Why?
|
| Th1 Cells | 2 | 2013 | 1057 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3508 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5181 | 0.040 |
Why?
|
| CpG Islands | 3 | 2016 | 1172 | 0.040 |
Why?
|
| Contig Mapping | 1 | 1999 | 54 | 0.040 |
Why?
|
| Valproic Acid | 1 | 1982 | 445 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1988 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 1981 | 298 | 0.040 |
Why?
|
| Serotonin Antagonists | 1 | 2000 | 144 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2014 | 6442 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2014 | 5179 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 2000 | 136 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 7729 | 0.040 |
Why?
|
| Antigens, CD19 | 2 | 2015 | 380 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2006 | 795 | 0.040 |
Why?
|
| Ganglioglioma | 1 | 2019 | 42 | 0.040 |
Why?
|
| Ondansetron | 1 | 2000 | 90 | 0.040 |
Why?
|
| Ileum | 1 | 2022 | 565 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2002 | 981 | 0.040 |
Why?
|
| Population Growth | 1 | 2019 | 52 | 0.040 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2019 | 6 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 810 | 0.040 |
Why?
|
| Drosophila Proteins | 2 | 2006 | 1703 | 0.040 |
Why?
|
| Japan | 2 | 2020 | 1360 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3846 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 729 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2019 | 1859 | 0.040 |
Why?
|
| Immunogenetics | 1 | 2019 | 67 | 0.040 |
Why?
|
| Pseudogenes | 2 | 2002 | 113 | 0.040 |
Why?
|
| Protein Array Analysis | 2 | 2016 | 411 | 0.040 |
Why?
|
| Myeloma Proteins | 1 | 1999 | 72 | 0.040 |
Why?
|
| Iceland | 1 | 2019 | 183 | 0.040 |
Why?
|
| Trichloroethylene | 1 | 1998 | 13 | 0.040 |
Why?
|
| Parents | 3 | 2021 | 3407 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2021 | 367 | 0.040 |
Why?
|
| Lipoproteins, HDL | 2 | 2020 | 638 | 0.040 |
Why?
|
| Norway | 1 | 2020 | 448 | 0.040 |
Why?
|
| Dyspepsia | 1 | 2000 | 115 | 0.040 |
Why?
|
| Monocytes | 2 | 2020 | 2596 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 213 | 0.040 |
Why?
|
| Ions | 1 | 2000 | 265 | 0.040 |
Why?
|
| Glycerol | 1 | 2000 | 278 | 0.040 |
Why?
|
| Dementia | 1 | 2013 | 2518 | 0.040 |
Why?
|
| Glycomics | 1 | 2020 | 121 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1999 | 878 | 0.040 |
Why?
|
| Bone Density | 5 | 2003 | 3468 | 0.040 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 1420 | 0.040 |
Why?
|
| Biological Transport | 3 | 2013 | 2118 | 0.040 |
Why?
|
| Oxygenases | 1 | 1998 | 60 | 0.040 |
Why?
|
| Thrombospondins | 1 | 2019 | 197 | 0.040 |
Why?
|
| DNA Primers | 7 | 1996 | 2892 | 0.040 |
Why?
|
| Bacterial Proteins | 5 | 2011 | 3848 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.040 |
Why?
|
| Impulsive Behavior | 1 | 2021 | 316 | 0.040 |
Why?
|
| Role | 1 | 1999 | 175 | 0.040 |
Why?
|
| Italy | 2 | 2012 | 832 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2001 | 319 | 0.040 |
Why?
|
| Motivation | 1 | 2008 | 1971 | 0.040 |
Why?
|
| Radiology | 2 | 2009 | 2100 | 0.040 |
Why?
|
| Paraproteins | 1 | 2018 | 39 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2021 | 881 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2019 | 153 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2001 | 337 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2018 | 101 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 1999 | 182 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2000 | 420 | 0.040 |
Why?
|
| Food Preservation | 1 | 1997 | 14 | 0.040 |
Why?
|
| Professional Competence | 1 | 2001 | 447 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8863 | 0.040 |
Why?
|
| Fear | 1 | 2006 | 1440 | 0.040 |
Why?
|
| Genes, APC | 1 | 1998 | 159 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 349 | 0.040 |
Why?
|
| Enterocytes | 1 | 2019 | 225 | 0.040 |
Why?
|
| Australia | 3 | 2008 | 1170 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 2505 | 0.040 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10180 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
| Heart Rate | 1 | 2009 | 4091 | 0.040 |
Why?
|
| Neuregulins | 1 | 2017 | 35 | 0.040 |
Why?
|
| Domestic Violence | 1 | 1999 | 176 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 377 | 0.040 |
Why?
|
| Food Microbiology | 1 | 1997 | 78 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 2017 | 53 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2018 | 133 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1997 | 126 | 0.040 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2725 | 0.040 |
Why?
|
| Syndactyly | 1 | 1997 | 72 | 0.040 |
Why?
|
| Americas | 1 | 2017 | 111 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 13989 | 0.040 |
Why?
|
| Medical Errors | 1 | 2006 | 1297 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 387 | 0.040 |
Why?
|
| Kidney | 3 | 2016 | 7186 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14722 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 428 | 0.040 |
Why?
|
| Pruritus | 1 | 2000 | 361 | 0.040 |
Why?
|
| Poland | 2 | 2007 | 184 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.040 |
Why?
|
| Mississippi | 1 | 2016 | 88 | 0.040 |
Why?
|
| Attention | 1 | 2007 | 2400 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 1999 | 289 | 0.040 |
Why?
|
| Fenofibrate | 1 | 2016 | 88 | 0.040 |
Why?
|
| Artifacts | 2 | 2020 | 1904 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 315 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 2016 | 25625 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 1996 | 70 | 0.030 |
Why?
|
| Population Dynamics | 2 | 2008 | 302 | 0.030 |
Why?
|
| Pakistan | 1 | 2017 | 295 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2010 | 133 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2016 | 140 | 0.030 |
Why?
|
| Lysine | 2 | 2015 | 1007 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 97 | 0.030 |
Why?
|
| Parkinsonian Disorders | 1 | 2019 | 275 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2016 | 194 | 0.030 |
Why?
|
| Health Promotion | 1 | 2008 | 2205 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2004 | 1338 | 0.030 |
Why?
|
| Gastric Acid | 2 | 1986 | 104 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1997 | 274 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2000 | 4217 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2010 | 1063 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2000 | 577 | 0.030 |
Why?
|
| Age Factors | 4 | 2020 | 18370 | 0.030 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 202 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2015 | 27 | 0.030 |
Why?
|
| Endoscopy | 1 | 2005 | 1785 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 326 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2003 | 386 | 0.030 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 984 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2001 | 1463 | 0.030 |
Why?
|
| Ubiquitin | 2 | 2012 | 852 | 0.030 |
Why?
|
| Sertraline | 1 | 2016 | 206 | 0.030 |
Why?
|
| Leukocytes | 2 | 2020 | 2043 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 226 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 504 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 2734 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1998 | 415 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3752 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 12354 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 905 | 0.030 |
Why?
|
| Diet | 2 | 2012 | 7939 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2001 | 1147 | 0.030 |
Why?
|
| Video Recording | 1 | 2000 | 949 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 1997 | 349 | 0.030 |
Why?
|
| Phagosomes | 1 | 2016 | 193 | 0.030 |
Why?
|
| Kinetics | 2 | 2014 | 6473 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2019 | 1588 | 0.030 |
Why?
|
| Nipples | 1 | 1997 | 219 | 0.030 |
Why?
|
| Cholesterol | 2 | 2021 | 2917 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2018 | 3002 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3505 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 2000 | 585 | 0.030 |
Why?
|
| Sex Offenses | 1 | 1999 | 354 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 386 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 4217 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1142 | 0.030 |
Why?
|
| Metagenome | 1 | 2018 | 418 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 7181 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2018 | 591 | 0.030 |
Why?
|
| Blood Pressure | 4 | 2016 | 8554 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2015 | 142 | 0.030 |
Why?
|
| Complement C3b | 1 | 2014 | 106 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2016 | 8324 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1999 | 638 | 0.030 |
Why?
|
| Ciliary Body | 1 | 2015 | 173 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2021 | 1640 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2015 | 794 | 0.030 |
Why?
|
| Aorta | 1 | 2022 | 2061 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4931 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 339 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1988 | 2645 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2187 | 0.030 |
Why?
|
| Treatment Outcome | 7 | 2020 | 63114 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1903 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 690 | 0.030 |
Why?
|
| Income | 1 | 2023 | 1913 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1998 | 541 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3255 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3479 | 0.030 |
Why?
|
| Adipokines | 1 | 2016 | 319 | 0.030 |
Why?
|
| Models, Animal | 2 | 2016 | 2171 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 844 | 0.030 |
Why?
|
| Mice, Inbred A | 2 | 2008 | 248 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 706 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15540 | 0.030 |
Why?
|
| Germ Cells | 1 | 2018 | 631 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 2538 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2007 | 563 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1998 | 981 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1848 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2540 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 885 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 20 | 0.030 |
Why?
|
| Collagen | 1 | 2022 | 2689 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2020 | 1053 | 0.030 |
Why?
|
| Disease Progression | 4 | 2012 | 13284 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2007 | 20129 | 0.030 |
Why?
|
| Sulfates | 1 | 1994 | 390 | 0.030 |
Why?
|
| Smoking | 3 | 2019 | 8987 | 0.030 |
Why?
|
| Gliosis | 1 | 2014 | 245 | 0.030 |
Why?
|
| Amidine-Lyases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2000 | 1359 | 0.030 |
Why?
|
| DNA Damage | 3 | 1999 | 2432 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2000 | 861 | 0.030 |
Why?
|
| Education | 1 | 2016 | 543 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 899 | 0.030 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2012 | 34 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1999 | 624 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2002 | 798 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 2505 | 0.030 |
Why?
|
| Hybridization, Genetic | 2 | 2005 | 109 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1171 | 0.030 |
Why?
|
| Dendrites | 1 | 2016 | 485 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2010 | 1081 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1470 | 0.030 |
Why?
|
| Prospective Studies | 9 | 2012 | 53288 | 0.030 |
Why?
|
| Canada | 2 | 2013 | 2065 | 0.030 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1997 | 379 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
| Myoma | 1 | 1992 | 10 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2013 | 117 | 0.030 |
Why?
|
| Proinsulin | 1 | 2012 | 133 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1997 | 839 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1185 | 0.030 |
Why?
|
| Croatia | 1 | 2012 | 35 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1106 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2000 | 1881 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2015 | 10252 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1997 | 748 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 100 | 0.030 |
Why?
|
| Communication | 2 | 1999 | 3749 | 0.030 |
Why?
|
| Aquaporins | 1 | 2013 | 174 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 8949 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.030 |
Why?
|
| Phylogeography | 1 | 2012 | 82 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 892 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 2006 | 448 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 780 | 0.030 |
Why?
|
| Scotland | 1 | 2012 | 155 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 1991 | 10 | 0.030 |
Why?
|
| von Willebrand Diseases | 1 | 1993 | 127 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3129 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 604 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 934 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1993 | 455 | 0.030 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 119 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 2004 | 1169 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 730 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 1152 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2002 | 8428 | 0.030 |
Why?
|
| Intelligence | 1 | 2017 | 920 | 0.030 |
Why?
|
| Iduronidase | 1 | 2011 | 31 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 752 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2007 | 3309 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 9734 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 2699 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 159 | 0.030 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 1060 | 0.030 |
Why?
|
| Neurons | 2 | 2022 | 9338 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2866 | 0.030 |
Why?
|
| Complement Activation | 1 | 2013 | 453 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 272 | 0.020 |
Why?
|
| Uterus | 2 | 1993 | 711 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1637 | 0.020 |
Why?
|
| Calcitriol | 1 | 1993 | 298 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2011 | 49 | 0.020 |
Why?
|
| Picolinic Acids | 1 | 2011 | 53 | 0.020 |
Why?
|
| Deferoxamine | 1 | 1991 | 151 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2014 | 287 | 0.020 |
Why?
|
| Genomic Library | 2 | 2005 | 193 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 1602 | 0.020 |
Why?
|
| Progestins | 1 | 1993 | 306 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 54 | 0.020 |
Why?
|
| Proteome | 2 | 2016 | 1799 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1061 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2016 | 899 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2012 | 409 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2011 | 118 | 0.020 |
Why?
|
| Apoptosis | 3 | 2016 | 9727 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 557 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3278 | 0.020 |
Why?
|
| Speech Recognition Software | 1 | 2011 | 72 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2000 | 1786 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 707 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2003 | 7913 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 1144 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 381 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1992 | 236 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| tau Proteins | 1 | 2020 | 1868 | 0.020 |
Why?
|
| Alkalosis | 1 | 1990 | 54 | 0.020 |
Why?
|
| Parathyroid Hormone | 3 | 1993 | 1801 | 0.020 |
Why?
|
| ROC Curve | 2 | 2008 | 3527 | 0.020 |
Why?
|
| Statistics as Topic | 3 | 2006 | 2373 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 976 | 0.020 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2010 | 77 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4371 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2014 | 957 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 104 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 1000 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2017 | 1379 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2005 | 1266 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 635 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 1991 | 339 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3420 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1998 | 1524 | 0.020 |
Why?
|
| Renin | 1 | 2012 | 642 | 0.020 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2011 | 136 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 141 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
| Fruit | 1 | 1995 | 1142 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 804 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 188 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3340 | 0.020 |
Why?
|
| Liver | 2 | 2020 | 7474 | 0.020 |
Why?
|
| Meiosis | 2 | 2006 | 339 | 0.020 |
Why?
|
| Phytosterols | 1 | 2009 | 64 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2009 | 50 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 970 | 0.020 |
Why?
|
| Complement C2 | 1 | 2008 | 72 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1832 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 695 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1993 | 912 | 0.020 |
Why?
|
| Glutamates | 1 | 1990 | 398 | 0.020 |
Why?
|
| Time | 1 | 2011 | 542 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2010 | 132 | 0.020 |
Why?
|
| Semaphorins | 1 | 2009 | 101 | 0.020 |
Why?
|
| Complement Factor B | 1 | 2008 | 72 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1999 | 1886 | 0.020 |
Why?
|
| Karyotyping | 1 | 2011 | 1243 | 0.020 |
Why?
|
| Parity | 2 | 2004 | 929 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Heparin | 2 | 1998 | 1637 | 0.020 |
Why?
|
| Valine | 1 | 1990 | 413 | 0.020 |
Why?
|
| Patient Satisfaction | 2 | 2000 | 3396 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 554 | 0.020 |
Why?
|
| Research Design | 1 | 2004 | 5987 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 1990 | 351 | 0.020 |
Why?
|
| Saccharin | 1 | 2008 | 20 | 0.020 |
Why?
|
| DNA, Neoplasm | 4 | 1997 | 1758 | 0.020 |
Why?
|
| Ploidies | 2 | 2000 | 281 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1538 | 0.020 |
Why?
|
| Linguistics | 1 | 2008 | 97 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 601 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
| Equipment Design | 2 | 2007 | 3582 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2240 | 0.020 |
Why?
|
| Flowers | 1 | 2008 | 28 | 0.020 |
Why?
|
| Survival Rate | 2 | 2017 | 12788 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 449 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2009 | 256 | 0.020 |
Why?
|
| Glycine | 2 | 2004 | 671 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2011 | 359 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1991 | 2025 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 212 | 0.020 |
Why?
|
| Diacetyl | 1 | 1987 | 21 | 0.020 |
Why?
|
| Acidosis | 1 | 1990 | 270 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 972 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 16689 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3520 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 2988 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1850 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1161 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1684 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 1987 | 110 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2531 | 0.020 |
Why?
|
| Calmodulin | 1 | 1988 | 209 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2009 | 270 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 1990 | 0.020 |
Why?
|
| Body Weight | 2 | 2008 | 4669 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10943 | 0.020 |
Why?
|
| Social Alienation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Isoantigens | 1 | 1990 | 567 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1999 | 2541 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 1997 | 1643 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 329 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1422 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4386 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 496 | 0.020 |
Why?
|
| Peptides | 2 | 1992 | 4409 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2008 | 246 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 2007 | 134 | 0.020 |
Why?
|
| Systems Integration | 1 | 2009 | 440 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5078 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 349 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2010 | 673 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1549 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1987 | 315 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 503 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 1205 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12245 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3772 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 2121 | 0.020 |
Why?
|
| Perfusion | 2 | 1990 | 1360 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2006 | 61 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 5892 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 816 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 25043 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1987 | 390 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1406 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2010 | 582 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2035 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1987 | 683 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 1997 | 642 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 688 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 931 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4560 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2008 | 2585 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 395 | 0.020 |
Why?
|
| Depression | 2 | 2023 | 7766 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2006 | 154 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2005 | 40 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2008 | 475 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 216 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 841 | 0.020 |
Why?
|
| Estrogens | 1 | 1993 | 1566 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1488 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2005 | 27 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2000 | 2050 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 2519 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1338 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 986 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1406 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 173 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2005 | 27 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 898 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2009 | 559 | 0.020 |
Why?
|
| Morbidity | 2 | 2002 | 1769 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 1986 | 97 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2006 | 235 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3587 | 0.020 |
Why?
|
| Testosterone | 1 | 2016 | 2420 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 411 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2006 | 193 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2006 | 471 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 1312 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1999 | 3209 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 91 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 433 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2005 | 229 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2005 | 138 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1801 | 0.020 |
Why?
|
| Codon | 1 | 2006 | 611 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 743 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 2472 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 1751 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1994 | 1583 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2838 | 0.020 |
Why?
|
| Azores | 1 | 2004 | 6 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1970 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1801 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2004 | 39 | 0.020 |
Why?
|
| Glioma | 1 | 2019 | 3401 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 3923 | 0.020 |
Why?
|
| Netherlands | 1 | 2009 | 2170 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 329 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2006 | 381 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 298 | 0.010 |
Why?
|
| Lung | 2 | 2005 | 9856 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1993 | 1888 | 0.010 |
Why?
|
| Space Perception | 1 | 2007 | 475 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 574 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 2004 | 3616 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 936 | 0.010 |
Why?
|
| Microsomes | 1 | 2003 | 257 | 0.010 |
Why?
|
| Membrane Transport Proteins | 2 | 2003 | 1028 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 592 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 578 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 357 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2008 | 1041 | 0.010 |
Why?
|
| Symporters | 1 | 2006 | 362 | 0.010 |
Why?
|
| Wisconsin | 1 | 2003 | 124 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2386 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2004 | 185 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2005 | 250 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 928 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1990 | 1348 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 1982 | 60 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1986 | 599 | 0.010 |
Why?
|
| Osteitis Deformans | 1 | 1982 | 53 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1723 | 0.010 |
Why?
|
| Organ Size | 1 | 2008 | 2252 | 0.010 |
Why?
|
| Carcinoma | 1 | 1994 | 2375 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2003 | 171 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2008 | 1609 | 0.010 |
Why?
|
| Base Composition | 1 | 2002 | 293 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6314 | 0.010 |
Why?
|
| Nerve Net | 1 | 2014 | 2174 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 611 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2002 | 105 | 0.010 |
Why?
|
| Fluorouracil | 2 | 1999 | 1619 | 0.010 |
Why?
|
| Carrier State | 1 | 2006 | 518 | 0.010 |
Why?
|
| Radiometry | 1 | 2007 | 800 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 1475 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9274 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2002 | 229 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2011 | 77449 | 0.010 |
Why?
|
| Iodohippuric Acid | 1 | 1981 | 8 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 238 | 0.010 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1982 | 126 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 1836 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2216 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3821 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8388 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11124 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2014 | 2071 | 0.010 |
Why?
|
| Alcoholism | 1 | 2012 | 1906 | 0.010 |
Why?
|
| Oocytes | 1 | 2006 | 1187 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2362 | 0.010 |
Why?
|
| Cadaver | 1 | 2005 | 1337 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.010 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 1981 | 79 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 1009 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2000 | 13102 | 0.010 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2001 | 14 | 0.010 |
Why?
|
| Skin | 1 | 2015 | 4364 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2001 | 189 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2001 | 197 | 0.010 |
Why?
|
| International Cooperation | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1643 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 475 | 0.010 |
Why?
|
| Foot Deformities, Congenital | 1 | 2000 | 59 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 2001 | 189 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2007 | 2025 | 0.010 |
Why?
|
| Acute Disease | 2 | 1999 | 7149 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 6622 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2004 | 484 | 0.010 |
Why?
|
| Visual Fields | 1 | 2007 | 1047 | 0.010 |
Why?
|
| Thermus | 1 | 1999 | 11 | 0.010 |
Why?
|
| Solvents | 1 | 2001 | 302 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1992 | 803 | 0.010 |
Why?
|
| GATA3 Transcription Factor | 1 | 2000 | 157 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1660 | 0.010 |
Why?
|
| Calpain | 1 | 2000 | 150 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2232 | 0.010 |
Why?
|
| Enzymes | 1 | 2001 | 266 | 0.010 |
Why?
|
| Delayed-Action Preparations | 2 | 1994 | 968 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4456 | 0.010 |
Why?
|
| Weight Gain | 1 | 2010 | 2292 | 0.010 |
Why?
|
| Northern Territory | 1 | 1999 | 5 | 0.010 |
Why?
|
| DNA, Circular | 1 | 1999 | 97 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.010 |
Why?
|
| Radiography | 2 | 2000 | 7023 | 0.010 |
Why?
|
| Mothers | 2 | 2000 | 2165 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2480 | 0.010 |
Why?
|
| Catalase | 1 | 1999 | 222 | 0.010 |
Why?
|
| Psoriasis | 1 | 2007 | 898 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 1241 | 0.010 |
Why?
|
| Antithrombin Proteins | 1 | 1998 | 9 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2006 | 5524 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2003 | 417 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3282 | 0.010 |
Why?
|
| Uremia | 1 | 2000 | 201 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 453 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2005 | 1211 | 0.010 |
Why?
|
| Israel | 1 | 2001 | 796 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1375 | 0.010 |
Why?
|
| Drosophila | 1 | 2006 | 1491 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 458 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 1999 | 3479 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1998 | 237 | 0.010 |
Why?
|
| North Carolina | 1 | 1999 | 315 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 919 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1988 | 1938 | 0.010 |
Why?
|
| Computers | 1 | 2001 | 612 | 0.010 |
Why?
|
| Alanine | 1 | 2000 | 572 | 0.010 |
Why?
|
| Wetting Agents | 1 | 1997 | 2 | 0.010 |
Why?
|
| Glutathione | 1 | 1960 | 589 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 273 | 0.010 |
Why?
|
| Factor V | 1 | 1998 | 178 | 0.010 |
Why?
|
| Threonine | 1 | 1998 | 279 | 0.010 |
Why?
|
| Bone and Bones | 2 | 2000 | 2575 | 0.010 |
Why?
|
| Candy | 1 | 1997 | 37 | 0.010 |
Why?
|
| Diphosphonates | 1 | 1982 | 623 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1620 | 0.010 |
Why?
|
| Fathers | 1 | 2000 | 358 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 876 | 0.010 |
Why?
|
| Interleukin-9 | 1 | 1997 | 63 | 0.010 |
Why?
|
| Ectoderm | 1 | 1997 | 137 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 444 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4665 | 0.010 |
Why?
|
| Meat Products | 1 | 1997 | 99 | 0.010 |
Why?
|
| Family Practice | 1 | 2000 | 516 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1981 | 2031 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6364 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 597 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2765 | 0.010 |
Why?
|
| Humidity | 1 | 1997 | 197 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 1997 | 200 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1998 | 414 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2001 | 739 | 0.010 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 1997 | 91 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 562 | 0.010 |
Why?
|
| Gastrins | 2 | 1986 | 81 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 335 | 0.010 |
Why?
|
| China | 1 | 2002 | 2248 | 0.010 |
Why?
|
| Gastric Fundus | 2 | 1986 | 39 | 0.010 |
Why?
|
| Oxygen | 1 | 1988 | 4189 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1997 | 291 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1999 | 404 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 913 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2002 | 1877 | 0.010 |
Why?
|
| Spine | 2 | 1993 | 1144 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4215 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1982 | 1092 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 640 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 1227 | 0.010 |
Why?
|
| Patient Care Management | 1 | 1999 | 306 | 0.010 |
Why?
|
| Omeprazole | 2 | 1986 | 112 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1981 | 1050 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 118 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1997 | 318 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1994 | 28 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1995 | 235 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8436 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 195 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 441 | 0.010 |
Why?
|
| Reproduction | 1 | 2000 | 668 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1993 | 4933 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4479 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1994 | 103 | 0.010 |
Why?
|
| Familial Mediterranean Fever | 1 | 1995 | 61 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2029 | 0.010 |
Why?
|
| Norethindrone | 1 | 1994 | 59 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1991 | 865 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1997 | 661 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2001 | 1257 | 0.010 |
Why?
|
| Seafood | 1 | 1997 | 384 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2002 | 1035 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 1996 | 579 | 0.010 |
Why?
|
| Anion Transport Proteins | 1 | 1994 | 142 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1994 | 11524 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1770 | 0.010 |
Why?
|
| Dairy Products | 1 | 1997 | 498 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1993 | 170 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1993 | 94 | 0.010 |
Why?
|
| Estrone | 1 | 1994 | 240 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 560 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 111 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11366 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35421 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 636 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 1993 | 164 | 0.010 |
Why?
|
| Proteinuria | 1 | 1996 | 658 | 0.010 |
Why?
|
| Recurrence | 2 | 1996 | 8340 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 313 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1993 | 6489 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1999 | 1486 | 0.010 |
Why?
|
| Annexins | 1 | 1992 | 38 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1583 | 0.010 |
Why?
|
| Extremities | 1 | 1997 | 865 | 0.010 |
Why?
|
| Colectomy | 1 | 1997 | 683 | 0.010 |
Why?
|
| Brain Stem | 1 | 1997 | 846 | 0.010 |
Why?
|
| Chromogenic Compounds | 1 | 1991 | 30 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1999 | 1092 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1994 | 8642 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1992 | 232 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1997 | 927 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1989 | 5221 | 0.010 |
Why?
|
| Alkalosis, Respiratory | 1 | 1990 | 19 | 0.010 |
Why?
|
| Acidosis, Respiratory | 1 | 1990 | 37 | 0.010 |
Why?
|
| Buffers | 1 | 1990 | 147 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1581 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1981 | 2149 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1990 | 517 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1990 | 269 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1991 | 684 | 0.010 |
Why?
|
| Tretinoin | 1 | 1992 | 517 | 0.010 |
Why?
|
| Colonoscopy | 1 | 1997 | 1367 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1991 | 409 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1997 | 1809 | 0.010 |
Why?
|
| Cisplatin | 1 | 1994 | 1662 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1999 | 3086 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 1990 | 247 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2899 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3584 | 0.000 |
Why?
|
| Disease Management | 1 | 1999 | 2459 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1993 | 1959 | 0.000 |
Why?
|
| Pain Measurement | 1 | 1997 | 3420 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 2245 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 1353 | 0.000 |
Why?
|
| Kidney Calculi | 1 | 1991 | 465 | 0.000 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 1997 | 1462 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 1622 | 0.000 |
Why?
|
| Achlorhydria | 1 | 1986 | 11 | 0.000 |
Why?
|
| Ranitidine | 1 | 1986 | 34 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 3966 | 0.000 |
Why?
|
| Pyloric Antrum | 1 | 1986 | 69 | 0.000 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 1997 | 1458 | 0.000 |
Why?
|
| Child Abuse, Sexual | 1 | 1989 | 383 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12026 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1999 | 5391 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1919 | 0.000 |
Why?
|
| Anxiety | 1 | 2000 | 4297 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1991 | 1189 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7785 | 0.000 |
Why?
|
| Estradiol | 1 | 1992 | 2020 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1986 | 719 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11031 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1981 | 4262 | 0.000 |
Why?
|
| Somatostatin | 1 | 1986 | 459 | 0.000 |
Why?
|
| Glucagon | 1 | 1986 | 533 | 0.000 |
Why?
|
| Hydroxyproline | 1 | 1982 | 116 | 0.000 |
Why?
|
| Decision Making | 1 | 1997 | 3887 | 0.000 |
Why?
|
| Adaptation, Psychological | 1 | 1993 | 2576 | 0.000 |
Why?
|
| Substance-Related Disorders | 1 | 1999 | 4258 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1982 | 276 | 0.000 |
Why?
|
| Cell Division | 1 | 1990 | 4568 | 0.000 |
Why?
|
| Wound Infection | 1 | 1964 | 242 | 0.000 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1990 | 1838 | 0.000 |
Why?
|
| Gastrectomy | 1 | 1986 | 663 | 0.000 |
Why?
|
| Benzimidazoles | 1 | 1986 | 850 | 0.000 |
Why?
|
| Health Personnel | 1 | 1993 | 3218 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1993 | 5985 | 0.000 |
Why?
|
| Quality of Life | 1 | 1998 | 12804 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1964 | 1400 | 0.000 |
Why?
|
| Cross Infection | 1 | 1964 | 1416 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 13695 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1964 | 613 | 0.000 |
Why?
|